Clinical trials: What to know before you invest | Health & Wealth #9 (Episode in English)

When developing new therapies or medicines, there are many hurdles along the way to reaching the market. If you do, that is. Failure is lurking at every step. A drug candidate must be safe and show clinicial efficacy in patients without severe side effects. The risks are significant and so are the costs, but if a project is successful, the reward could be enormous. So, how can you assess the risks involved?

I det här avsnittet av Health & Wealth går Jesper Prior Larsen från Aixial Group – ett ledande bolag inom kliniska studier – igenom några avgörande aspekter att känna till innan man investerar i life science.

Se intervjun på biostock.se:

https://www.biostock.se/health-and-wealth/?utm_source=mail&utm_medium=mail&utm_campaign=hw&utm_id=hw

Detta är ett pressmeddelande från BioStock – Connecting Innovation & Capital. https://www.biostock.se